SCHEMBL25978664

SCHEMBL25978664

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)oc3ccc(N(c5ccccc5)c5cccc6ccccc56)cc34)n2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.34
TSHR P16473 5/20 0.34
KDM4E B2RXH2 5/20 0.34
HPGD P15428 5/20 0.34
ALDH1A1 P00352 4/20 0.34
HSD17B10 Q99714 3/20 0.34
ALOX15 P16050 1/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34
KMT2A Q03164 3/20 0.32
MAPK1 P28482 2/20 0.32
ABCG2 Q9UNQ0 2/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
TDP1 Q9NUW8 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
GLA P06280 2/20 0.32
HTT P42858 2/20 0.32
TP53 P04637 1/20 0.32
NFKB1 P19838 1/20 0.32
NFKB2 Q00653 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26779035 0.98 MAPT (0.34) MAPTTSHRKDM4EHPGDALDH1A1
SCHEMBL25978682 0.95 HPGD (0.35) MAPTTSHRKDM4EHPGDALDH1A1
SCHEMBL25979227 0.94 HCRTR1 (0.34) MAPTTSHRKDM4EHPGDALDH1A1
SCHEMBL25978939 0.94 PLA2G2A (0.34) MAPTTSHRKDM4EHPGDALDH1A1
SCHEMBL25979466 0.94 MAPT (0.34) MAPTTSHRKDM4EHPGDALDH1A1
SCHEMBL26779099 0.93 PLA2G2A (0.35) MAPTTSHRKDM4EHPGDALDH1A1
SCHEMBL25979761 0.92 CYP1A2 (0.34) MAPTTSHRKDM4EHPGDALDH1A1
SCHEMBL25979485 0.92 MAPT (0.34) MAPTTSHRKDM4EHPGDALDH1A1
SCHEMBL25979642 0.92 ALDH1A1 (0.34) MAPTTSHRKDM4EHPGDALDH1A1
SCHEMBL25978969 0.91 PLA2G2A (0.35) MAPTTSHRKDM4EHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
EP-4227301-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 MAPT 1428/4885TSHR 4037/4885KDM4E 2673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.